204 related articles for article (PubMed ID: 3826434)
1. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
2. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
3. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
[TBL] [Abstract][Full Text] [Related]
5. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
6. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
Georgotas A; McCue RE; Friedman E; Cooper TB
Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
Davidson J; McLeod MN; White HL
Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
Georgotas A; Mann J; Friedman E
Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
[No Abstract] [Full Text] [Related]
11. Response of psychotic and nonpsychotic depression to phenelzine.
Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
14. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Davidson J; McLeod MN; Blum MR
Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
[TBL] [Abstract][Full Text] [Related]
15. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Georgotas A; McCue RE; Cooper TB
Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
[TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity and age at onset of depression in elderly depressed women.
Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic determination of inhibition of monoamine oxidase activity in platelet rich plasma of depressed patients treated with phenelzine.
Gupta RN; Steiner M
Clin Chim Acta; 1985 Oct; 152(1-2):63-9. PubMed ID: 4053406
[TBL] [Abstract][Full Text] [Related]
20. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
